載入中
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
前收盤價
US$4.05
−US$0.04 · -0.98%
盤中時間採用ET。市場資料可能有所延遲。
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
日內區間
目前US$4.05
52週區間
目前US$4.05
盤中時間採用ET。市場資料可能有所延遲。
Outset Medical, Inc. is a medical technology firm that specializes in developing hemodialysis systems. The company's primary product is the Tablo Hemodialysis System, a compact console designed to deliver dialysis treatment in various environments, including hospitals and patients' homes. This innovative system boasts integrated water purification, on-demand production of dialysate, and advanced software complete with connectivity features. Founded in 2003, the company initially operated under the name Home Dialysis Plus, Ltd. before rebranding to Outset Medical, Inc. in January 2015. Its corporate headquarters are located in San Jose, California.
日內區間
目前US$4.05
52週區間
目前US$4.05
已公布業績及可用的市場共識預估。
已公布業績及可用的市場共識預估。
第三方分析師預期可能變動，並非 GoAI 建議。
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI211.18萬0.00%2.3兆 USD0.03%US$381.94+0.63%
Vanguard Extended Market ETFVXF78.9萬0.00%954億 USD0.05%US$235+0.80%
iShares Micro-Cap ETFIWC22.46萬0.02%13.17億 USD0.60%US$183+0.11%
Dimensional - US Small Cap ETFDFAS20.48萬0.00%338.69億 USD0.31%US$78.35+0.32%
Fidelity Disruptive Medicine ETFFMED13.91萬0.28%5231萬 USD0.50%US$31.4003+2.73%
Avantis U.S. Small Cap Equity ETFAVSC10.93萬—30.82億 USD0.25%US$69.98+0.03%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM10萬0.09%1.17億 USD0.73%US$15.9402+0.25%
Dimensional - US Core Equity 2 ETFDFAC9.95萬0.00%885.96億 USD0.21%US$45.33+0.49%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFiShares Micro-Cap ETFIWCDimensional - US Small Cap ETFDFASFidelity Disruptive Medicine ETFFMEDAvantis U.S. Small Cap Equity ETFAVSCEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMDimensional - US Core Equity 2 ETFDFACAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
